Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| IDEAYA Biosciences, Inc.(IDYA) | 2,100,000 | 3,000,000 | +900,000 | $66.53M | $77.10M | 9.02% | +$10.57M |
| Janux Therapeutics, Inc.(JANX) | 1,000,000 | 1,250,000 | +250,000 | $45.43M | $66.92M | 7.83% | +$21.50M |
| Revolution Medicines, Inc.(RVMD) | 1,200,000 | 1,450,000 | +250,000 | $54.42M | $63.42M | 7.42% | +$9.00M |
| Cytokinetics, Incorporated(CYTK) | 400,000 | 900,000 | +500,000 | $21.12M | $42.34M | 4.95% | +$21.22M |
| Vera Therapeutics, Inc.CL A(VERA) | 500,000 | 875,000 | +375,000 | $22.10M | $37.00M | 4.33% | +$14.90M |
| BioNTech SEADS(BNTX) | 0 | 300,000 | +300,000 | $0 | $34.19M | 4.00% | +$34.19M |
| Merus N V | 575,000 | 750,000 | +175,000 | $28.73M | $31.54M | 3.69% | +$2.81M |
| Erasca, Inc.(ERAS) | 10,900,000 | 12,500,000 | +1,600,000 | $29.76M | $31.38M | 3.67% | +$1.62M |
| Insmed Incorporated(INSM) | 0 | 450,000 | +450,000 | $0 | $31.07M | 3.64% | +$31.07M |
| Ocular Therapeutix, Inc.(OCUL) | 3,500,000 | 3,500,000 | 0 | $30.45M | $29.89M | 3.50% | -$560.0K |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 200,000 | +200,000 | $0 | $27.30M | 3.19% | +$27.30M |
| Design Therapeutics, Inc.(DSGN) | 4,217,627 | 4,217,627 | 0 | $22.69M | $26.02M | 3.04% | +$3.33M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 300,000 | 0 | $34.28M | $24.56M | 2.87% | -$9.72M |
| Akero Therapeutics Inc | 800,000 | 800,000 | 0 | $22.95M | $22.26M | 2.60% | -$696.0K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 175,000 | +175,000 | $0 | $21.55M | 2.52% | +$21.55M |
| Structure Therapeutics IncADS | 1,250,000 | 700,000 | -550,000 | $54.86M | $18.98M | 2.22% | -$35.88M |
| Olema Pharmaceuticals, Inc.(OLMA) | 3,208,875 | 3,208,875 | 0 | $38.31M | $18.71M | 2.19% | -$19.61M |
| Blueprint Medicines Corp | 0 | 200,000 | +200,000 | $0 | $17.44M | 2.04% | +$17.44M |
| Travere Therapeutics, Inc.(TVTX) | 1,100,000 | 1,000,000 | -100,000 | $15.39M | $17.42M | 2.04% | +$2.03M |
| Apellis Pharmaceuticals Inc COM | 0 | 500,000 | +500,000 | $0 | $15.96M | 1.87% | +$15.96M |
| Soleno Therapeutics Inc | 0 | 350,000 | +350,000 | $0 | $15.73M | 1.84% | +$15.73M |
| Alkermes plcSHS(ALKS) | 0 | 500,000 | +500,000 | $0 | $14.38M | 1.68% | +$14.38M |
| Apogee Therapeutics Inc | 0 | 300,000 | +300,000 | $0 | $13.59M | 1.59% | +$13.59M |
| Arvinas, Inc.(ARVN) | 400,000 | 700,000 | +300,000 | $9.85M | $13.42M | 1.57% | +$3.57M |
| Annexon, Inc.(ANNX) | 2,600,000 | 2,550,000 | -50,000 | $15.39M | $13.08M | 1.53% | -$2.31M |
| Disc Medicine, Inc.(IRON) | 935,000 | 200,000 | -735,000 | $45.95M | $12.68M | 1.48% | -$33.27M |
| Spyre Therapeutics, Inc.(SYRE) | 200,000 | 500,000 | +300,000 | $5.88M | $11.64M | 1.36% | +$5.76M |
| Edgewise Therapeutics, Inc.(EWTX) | 450,000 | 400,000 | -50,000 | $12.01M | $10.68M | 1.25% | -$1.33M |
| Dyne Therapeutics, Inc.(DYN) | 160,000 | 450,000 | +290,000 | $5.75M | $10.60M | 1.24% | +$4.85M |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 750,000 | +750,000 | $0 | $9.88M | 1.16% | +$9.88M |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 245,000 | +245,000 | $0 | $8.82M | 1.03% | +$8.82M |
| Y-Mabs Therapeutics Inc | 800,000 | 1,000,000 | +200,000 | $10.52M | $7.83M | 0.92% | -$2.69M |
| Immunovant, Inc.(IMVT) | 1,100,000 | 300,000 | -800,000 | $31.36M | $7.43M | 0.87% | -$23.93M |
| Geron Corporation(GERN) | 0 | 2,000,000 | +2,000,000 | $0 | $7.08M | 0.83% | +$7.08M |
| Aclaris Therapeutics, Inc.(ACRS) | 0 | 2,222,222 | +2,222,222 | $0 | $5.51M | 0.64% | +$5.51M |
| Trevi Therapeutics, Inc.(TRVI) | 2,750,000 | 1,250,000 | -1,500,000 | $9.19M | $5.15M | 0.60% | -$4.04M |
| Astria Therapeutics Inc | 500,000 | 500,000 | 0 | $5.50M | $4.47M | 0.52% | -$1.03M |
| Unicycive Therapeutics Inc | 5,078,927 | 5,078,927 | 0 | $2.07M | $4.03M | 0.47% | +$1.96M |
| Aerovate Therapeutics Inc | 0 | 1,400,000 | +1,400,000 | $0 | $3.71M | 0.43% | +$3.71M |
| Rapport Therapeutics, Inc.(RAPP) | 208,910 | 208,910 | 0 | $4.06M | $3.71M | 0.43% | -$358.5K |
| Atyr Pharma Inc | 2,000,000 | 1,000,000 | -1,000,000 | $3.52M | $3.62M | 0.42% | +$100.0K |
| Allakos Inc | 2,900,000 | 2,900,000 | 0 | $1.89M | $3.51M | 0.41% | +$1.61M |
| Enliven Therapeutics Inc | 495,000 | 140,000 | -355,000 | $12.64M | $3.15M | 0.37% | -$9.49M |
| Septerna, Inc.(SEPN) | 0 | 134,202 | +134,202 | $0 | $3.07M | 0.36% | +$3.07M |
| Artiva Biotherapeutics, Inc.(ARTV) | 145,089 | 145,089 | 0 | $2.13M | $1.46M | 0.17% | -$667.0K |
| Glycomimetics Inc | 0 | 5,400,000 | +5,400,000 | $0 | $1.34M | 0.16% | +$1.34M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 0 | 66,666 | +66,666 | $0 | $15.3K | 0.00% | +$15.3K |
| Adverum Biotechnologies Inc | 416,666 | 0 | -416,666 | $2.92M | $0 | — | -$2.92M |
| Avalo Therapeutics, Inc.(AVTX) | 539,079 | 0 | -539,079 | $5.12M | $0 | — | -$5.12M |
| Beam Therapeutics Inc.(BEAM) | 500,000 | 0 | -500,000 | $12.25M | $0 | — | -$12.25M |
| Bicara Therapeutics Inc | 800,000 | 0 | -800,000 | $20.38M | $0 | — | -$20.38M |
| Bicycle Therapeutics PlcADS | 500,000 | 0 | -500,000 | $11.31M | $0 | — | -$11.31M |
| Boundless Bio, Inc.(BOLD) | 58,903 | 0 | -58,903 | $204.4K | $0 | — | -$204.4K |
| Celldex Therapeutics, Inc.(CLDX) | 900,000 | 0 | -900,000 | $30.59M | $0 | — | -$30.59M |
| Cogent Biosciences, Inc.(COGT) | 2,000,000 | 0 | -2,000,000 | $21.60M | $0 | — | -$21.60M |
| COMPASS Pathways plcADS(CMPS) | 1,159,030 | 0 | -1,159,030 | $7.30M | $0 | — | -$7.30M |
| Cybin D/B/A Helus Pharma(HELP) | 600,000 | 0 | -600,000 | $5.33M | $0 | — | -$5.33M |
| Engene Holdings Inc COM | 800,000 | 0 | -800,000 | $5.28M | $0 | — | -$5.28M |
| Lakefront Biotherapeutics NVADR(LKFT) | 800,000 | 0 | -800,000 | $23.03M | $0 | — | -$23.03M |
| Io Biotech Inc | 493,827 | 0 | -493,827 | $518.5K | $0 | — | -$518.5K |
| Ionis Pharmaceuticals, Inc.(IONS) | 750,000 | 0 | -750,000 | $30.05M | $0 | — | -$30.05M |
| Lineage Cell Therapeutics, Inc.(LCTX) | 5,000,000 | 0 | -5,000,000 | $4.53M | $0 | — | -$4.53M |
| Neumora Therapeutics, Inc.(NMRA) | 100,000 | 0 | -100,000 | $1.32M | $0 | — | -$1.32M |
| Nextcure Inc | 2,500,000 | 0 | -2,500,000 | $3.42M | $0 | — | -$3.42M |
| Nuvalent Inc | 75,000 | 0 | -75,000 | $7.67M | $0 | — | -$7.67M |
| Oruka Therapeutics, Inc.(ORKA) | 257,330 | 0 | -257,330 | $6.31M | $0 | — | -$6.31M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 325,000 | 0 | -325,000 | $6.00M | $0 | — | -$6.00M |
| Sarepta Therapeutics, Inc.(SRPT) | 150,000 | 0 | -150,000 | $18.73M | $0 | — | -$18.73M |
| Silence Therapeutics plcADS(SLN) | 200,000 | 0 | -200,000 | $3.64M | $0 | — | -$3.64M |
| Skye Bioscience, Inc.(SKYE) | 100,000 | 0 | -100,000 | $391.0K | $0 | — | -$391.0K |